Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1Phase 1 1

Status

Completed 5Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Lymphoid 2Head & Neck 2Genitourinary 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1Classical hematology 1

Conditions

Colorectal Neoplasms 2Pancreatic Neoplasms 1Malnutrition 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Glutamine × Gastrointestinal × Clear all
NCT04634539 2025-08-06

Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

Cedars-Sinai Medical Center

Phase 1 Completed
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01552291 2018-02-13

Glutaminprojec

Insel Gruppe AG, University Hospital Bern

Phase 4 Completed
42 enrolled
Gastrointestinal

Digestive System Neoplasms, Malnutrition

NCT00255229 2016-02-25

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

AHS Cancer Control Alberta

Phase 2 Completed
130 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01087658 2013-06-21

GLUTOX

Sanofi

Phase 3 Completed
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00455247 2013-06-05

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

Société des Produits Nestlé (SPN)

Phase 3 Completed
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡